Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System Perspective
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6963
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System Perspective ; volume:15 ; number:1 ; day:5 ; month:11 ; year:2015 ; pages:1-11 ; date:6.2015
BMC health services research ; 15, Heft 1 (5.11.2015), 1-11, 6.2015
- Creator
-
Charokopou, M.
- Contributor
-
McEwan, P.
Lister, S.
Callan, L.
Bergenheim, K.
Tolley, K.
Postema, R.
Townsend, R.
Roudaut, M.
SpringerLink (Online service)
- DOI
-
10.1186/s12913-015-1139-y
- URN
-
urn:nbn:de:1111-2016110520402
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Charokopou, M.
- McEwan, P.
- Lister, S.
- Callan, L.
- Bergenheim, K.
- Tolley, K.
- Postema, R.
- Townsend, R.
- Roudaut, M.
- SpringerLink (Online service)
Other Objects (12)
Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes
Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
Effectiveness of Dapagliflozin as Add-On to Metformin with or without Other Oral Antidiabetic Drugs in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Database Study
Dapagliflozin/Metformin: Nutzenbewertung gemäß § 35a SGB V
Market Regulation of Voluntary Add-on Contracts
Shrouding add-on information: an experimental study
Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes
Homöopathie - Add-on : komplementäre Empfehlungen zur konventionellen Medizin
Add-on Pricing, Consumer Myopia and Regulatory Intervention
Auswahl und Integration einer anwendungsgerechten Add-on Hybridisierung
Add-on therapy in metformin-treated patients with type 2 diabetes at moderate cardiovascular risk: a nationwide study
Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus
Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes
Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
Effectiveness of Dapagliflozin as Add-On to Metformin with or without Other Oral Antidiabetic Drugs in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Database Study
Dapagliflozin/Metformin: Nutzenbewertung gemäß § 35a SGB V
Market Regulation of Voluntary Add-on Contracts
Shrouding add-on information: an experimental study
Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes
Homöopathie - Add-on : komplementäre Empfehlungen zur konventionellen Medizin
Add-on Pricing, Consumer Myopia and Regulatory Intervention
Auswahl und Integration einer anwendungsgerechten Add-on Hybridisierung
Add-on therapy in metformin-treated patients with type 2 diabetes at moderate cardiovascular risk: a nationwide study
Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus
Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes
Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
Effectiveness of Dapagliflozin as Add-On to Metformin with or without Other Oral Antidiabetic Drugs in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Database Study
Dapagliflozin/Metformin: Nutzenbewertung gemäß § 35a SGB V
Market Regulation of Voluntary Add-on Contracts
Shrouding add-on information: an experimental study
Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes
Homöopathie - Add-on : komplementäre Empfehlungen zur konventionellen Medizin
Add-on Pricing, Consumer Myopia and Regulatory Intervention
Auswahl und Integration einer anwendungsgerechten Add-on Hybridisierung
Add-on therapy in metformin-treated patients with type 2 diabetes at moderate cardiovascular risk: a nationwide study